Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Discovery and analysis of the C. elegans neuronal gene expression network (CENGEN)R01NS100547 · NINDS · YALE UNIVERSITY · PI MARC HAMMARLUND, Oliver Hobert · 2017 to 2026
$11.2M
VANTAGE:Consolidation to create the Vanderbilt Technologies for Advanced GenomicsG20RR030956 · NCRR · VANDERBILT UNIVERSITY · PI PIETENPOL, JENNIFER A · 2010 to 2010
$8.7M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
SUPPORT FOR THE ROSE F KENNEDY IDDRC P50P50HD105352 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Julie Secombe · 2021 to 2026
$7.0M
Hox-dependent mechanisms for establishment and maintenance of motor neuron terminal identityR01NS116365 · NINDS · UNIVERSITY OF CHICAGO · PI KRATSIOS, PASCHALIS · 2020 to 2024
$2.0M
Molecular mechanisms for neuron-specific assembly of electrical synapsesR01NS113559 · NINDS · VANDERBILT UNIVERSITY · PI MILLER, DAVID M · 2020 to 2024
$1.8M
Molecular mechanisms of motor neuron terminal identityR01NS118078 · NINDS · UNIVERSITY OF CHICAGO · PI KRATSIOS, PASCHALIS · 2020 to 2024
$1.8M
NCI NIH HHS P30 CA068485NCRR NIH HHS G20 RR030956NCRR NIH HHS UL1 RR024975NEI NIH HHS P30 EY008126NICHD NIH HHS P50 HD105352NIDDK NIH HHS P30 DK058404NIDDK NIH HHS U24 DK059637NIH HHS P40 OD010440NINDS NIH HHS K99 NS140549NINDS NIH HHS R01 NS100547NINDS NIH HHS R01 NS113559NINDS NIH HHS R01 NS116365NINDS NIH HHS R01 NS118078NINDS NIH HHS R21 NS108505U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) K99 NS140549-01U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS100547U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS113559U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01 NS116365U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01 NS118078U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R21 NS108505U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD) OD R24 010943
6 · The paper itself
Abstract
Transcription factors are central to neuronal development, yet their functions beyond the cells in which they are expressed remain poorly understood. Here, we uncover unexpected non-cell-autonomous roles for UNC-3, a terminal selector of cholinergic motor neuron identity in C. elegans, whose human ortholog (EBF3) is linked to a neurodevelopmental syndrome. Single-cell RNA-sequencing reveals unc-3 loss in cholinergic motor neurons elicits pronounced transcriptional changes in GABAergic motor neurons that do not express unc-3, which can be rescued by cholinergic-specific UNC-3 restoration. Mechanistically, gene network analysis identifies the pro-regenerative bZIP factor CEBP-1/CEBPB as a key driver of these transcriptional changes. At the circuit level, unc-3 loss causes synaptic and axon pathfinding defects in GABA motor neurons alongside misregulation of neurite development genes. Finally, UNC-3 not only acts as a direct transcriptional activator but also suppresses inappropriate gene expression through indirect mechanisms. Together, these findings broaden terminal selectors as both intrinsic and extrinsic regulators of neuronal identity and circuit assembly, providing a mechanistic framework for understanding EBF3-associated neurodevelopmental disease.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Intrinsic and non-cell-autonomous roles for the neurodevelopmental syndrome-linked transcription factor UNC-3/EBF. · full record | OpenQuestion